Federal Register / Vol. 77, No. 52 / Friday, March 16, 2012 / Notices 15783 

Name of Committee: National Cancer 

Institute Special Emphasis Panel NCI 

Experimental Therapeutics Program (NExT). 

Date: April 11, 2012. 

Time: 8:30 a.m.–4:30 p.m. 

Agenda: To evaluate the NCI Experimental 

Therapeutics Program Portfolio. 

Place: National Institutes of Health, 

Neuroscience Building, 6001 Executive 

Boulevard, Room C, Bethesda, MD 20814. 

Contact Person: Barbara Mroczkowski, 

Ph.D., Executive Secretary, NCI Experimental 

Therapeutics Program, National Cancer 

Institute, NIH 31 Center Drive, Room 3A44, 

Bethesda, MD 20817, (301) 496–4291, 

mroczkowskib@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 9, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–6345 Filed 3–15–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowships: 

Infectious Diseases and Microbiology. 

Date: March 22–23, 2012. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Alexander D Politis, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3210, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1150, politisa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel P01 Review: 

‘‘Presynaptic Mechanisms of Neural 

Plasticity’’. 

Date: April 3–4, 2012. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Joanne T Fujii, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4184, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1178, fujiij@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 9, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–6342 Filed 3–15–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel 

Nanotechnology Sensing Platforms. 

Date: March 26, 2012. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

National Cancer Institute, 6116 Executive 

Blvd., Conference Room 611, Rockville, MD 

20852, (Telephone Conference Call). 

Contact Person: Virginia P. Wray, Ph.D., 

Deputy Chief, Research Programs Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 6116 

Executive Blvd., Room 8125, Bethesda, MD 

20892–8328, 301–496–9236, 

wrayv@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 9, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–6337 Filed 3–15–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel Review of Program Project (P01) 

Application. 

Date: April 10, 2012. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3An12C, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Saraswathy Seetharam, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3An12C, 

Bethesda, MD 20892, 301–594–2763, 

seetharams@nigms.nih.gov. 

mstockstill on DSK4VPTVN1PROD with NOTICES

15784 Federal Register / Vol. 77, No. 52 / Friday, March 16, 2012 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: March 9, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–6336 Filed 3–15–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Ancillary Studies on 

T2D. 

Date: April 5, 2012. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Maria E. Davila-Bloom, 

Ph.D., Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 758, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davila-bloomm@extra.niddk.nih.

gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, NIDDK Diabetes 

Research Centers (P30). 

Date: June 4–5, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Najma Begum, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 749, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8894, 

begumn@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 9, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–6340 Filed 3–15–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2012–0212] 

Navigation Safety Advisory Council; 

Vacancies 

AGENCY: Coast Guard, DHS. 

ACTION: Request for applications. 

SUMMARY: The Coast Guard seeks 

applications for membership on the 

Navigation Safety Advisory Council 

(NAVSAC). NAVSAC provides advice 

and recommendations to the Secretary 

of Homeland Security, through the 

Commandant of the U.S. Coast Guard, 

on matters relating to maritime 

collisions, rammings, and groundings, 

Inland Rules of the Road, International 

Rules of the Road, navigation 

regulations and equipment, routing 

measures, marine information, diving 

safety, and aids to navigation systems. 

DATES: Applicants must submit a cover 

letter and resume on or before June 29, 

2012. 

ADDRESSES: Applicants should send a 

cover letter and resume to Mr. Mike 

Sollosi, Alternate Designated Federal 

Officer (ADFO), at the following 

address: Commandant (CG–553), Attn: 

Mr. Mike Sollosi, U.S. Coast Guard, 

2100 2nd Street SW., STOP 7580, 

Washington, DC 20593–7580. 

You can also call 202–372–1531 or 

email Dennis.Fahr@uscg.mil. This 

notice is available in our online docket 

USCG–2012–0212, at http://www.

regulations.gov. Members of the public 

should not submit personal information 

into a docket, as it becomes public 

record. During the vetting process, 

applicants may be asked to provide date 

of birth and social security number. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Mike Sollosi, the NAVSAC Alternate 

Designated Federal Officer (ADFO), at 

phone 202–372–1545, fax 202–372– 

1991, or email Mike.M.Sollosi@uscg.mil; 

or Mr. Dennis Fahr, at telephone 202– 

372–1531 or email Dennis.Fahr@uscg.

mil. 

SUPPLEMENTARY INFORMATION: The 

NAVSAC is a federal advisory 

committee authorized by 33 U.S.C. 2073 

and chartered under the Federal 

Advisory Committee Act (Pub. L. 92– 

463; 5 U.S.C. App. 2). The NAVSAC 

provides advice and recommendations 

to the Secretary, through the 

Commandant of the U.S. Coast Guard, 

on matters relating to maritime 

collisions, rammings, and groundings, 

Inland Rules of the Road, International 

Rules of the Road, navigation 

regulations and equipment, routing 

measures, marine information, diving 

safety, and aids to navigation systems. 

The NAVSAC is expected to meet at 

least twice each year, or more often with 

the approval of the Designated Federal 

Officer (DFO). Members may be 

reimbursed for travel and per diem, as 

allowed by regulations and Department 

policy. All travel for NAVSAC business 

must be approved in advance by the 

DFO. The NAVSAC is comprised of not 

more than 21 members who shall have 

expertise in Inland and International 

vessel navigation Rules of the Road, aids 

to maritime navigation, maritime law, 

vessel safety, port safety, or commercial 

diving safety. Each member shall be 

appointed to represent the viewpoints 

and interests of one of the following 

groups or organizations, and at least one 

member shall be appointed to represent 

each membership category: 

a. Commercial vessel owners or 

operators 

b. Professional mariners 

c. Recreational boaters 

d. The recreational boating industry 

e. State agencies responsible for vessel 

or port safety 

f. The Maritime Law Association. 

Members serve as representatives and 

are not Special Government Employees 

as defined in section 202(a) of Title 18, 

United States Code. 

The Coast Guard will consider 

applications for eight positions that will 

become vacant on November 4, 2012, in 

the following categories: 

a. Commercial vessel owners or 

operators 

b. Professional mariners 

c. Recreational boaters 

d. The recreational boating industry 

mstockstill on DSK4VPTVN1PROD with NOTICES